Tower Trust & Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.1K Buy
468
+8
+2% +$936 0.04% 131
2026
Q1
$55.3K Hold
460
0.04% 126
2025
Q4
$48.4K Hold
460
0.03% 127
2025
Q3
$38.6K Hold
460
0.03% 124
2025
Q2
$36.4K Hold
460
0.03% 129
2025
Q1
$39.2K Buy
+460
New +$42.9K 0.03% 125

Other funds holding MRK

Tower Trust & Investment Company's MRK Position: Q2 2026 in Review

Tower Trust & Investment Company increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $936 and bringing the position to 468 shares worth $60.1K. The position accounts for 0.04% of the portfolio, ranked #131.

Tower Trust & Investment Company first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tower Trust & Investment Company held 468 shares of Merck worth $60.1K as of Q2 2026.
  • Tower Trust & Investment Company bought 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.04% of Tower Trust & Investment Company's portfolio in Q2 2026, its #131 holding.
  • Tower Trust & Investment Company first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.